SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,310,051 | +5.5% | 60,304 | -0.4% | 0.03% | +13.0% |
| Q2 2023 | $6,930,521 | -15.8% | 60,518 | +1.4% | 0.02% | -17.9% |
| Q1 2023 | $8,226,384 | -34.9% | 59,685 | -38.8% | 0.03% | -39.1% |
| Q4 2022 | $12,643,639 | -41.7% | 97,574 | -50.3% | 0.05% | +7.0% |
| Q3 2022 | $21,689,527 | +48.1% | 196,210 | +0.4% | 0.04% | +59.3% |
| Q2 2022 | $14,645,992 | -5.9% | 195,384 | -1.9% | 0.03% | +22.7% |
| Q1 2022 | $15,560,440 | +73.5% | 199,192 | +100.0% | 0.02% | -4.3% |
| Q4 2021 | $8,969,000 | -1.5% | 99,597 | +1.2% | 0.02% | -11.5% |
| Q3 2021 | $9,101,000 | -38.2% | 98,407 | -48.1% | 0.03% | +23.8% |
| Q2 2021 | $14,738,000 | +93.9% | 189,580 | +85.9% | 0.02% | -8.7% |
| Q1 2021 | $7,601,000 | -38.0% | 101,989 | +41.9% | 0.02% | -39.5% |
| Q4 2020 | $12,255,000 | +26.5% | 71,882 | +4.2% | 0.04% | +8.6% |
| Q3 2020 | $9,688,000 | -59.7% | 68,985 | -54.0% | 0.04% | -25.5% |
| Q2 2020 | $24,048,000 | +84.4% | 149,980 | +12.5% | 0.05% | +42.4% |
| Q1 2020 | $13,044,000 | -19.7% | 133,342 | +5.9% | 0.03% | 0.0% |
| Q4 2019 | $16,248,000 | +75.4% | 125,912 | +2.4% | 0.03% | +83.3% |
| Q3 2019 | $9,262,000 | -50.5% | 122,972 | -0.2% | 0.02% | -51.4% |
| Q2 2019 | $18,716,000 | +90.7% | 123,170 | +49.5% | 0.04% | -2.6% |
| Q1 2019 | $9,816,000 | +3.4% | 82,361 | -5.3% | 0.04% | -7.3% |
| Q4 2018 | $9,490,000 | -32.5% | 86,961 | -0.1% | 0.04% | -21.2% |
| Q3 2018 | $14,061,000 | +22.1% | 87,061 | -0.1% | 0.05% | +18.2% |
| Q2 2018 | $11,514,000 | +160.8% | 87,107 | +46.2% | 0.04% | +144.4% |
| Q1 2018 | $4,415,000 | +261.6% | 59,593 | -29.4% | 0.02% | +260.0% |
| Q4 2014 | $1,221,000 | – | 84,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |